When was Perceptive Advisors founded?

Perceptive Advisors was founded in 1999.

Where is Perceptive Advisors headquartered?

Perceptive Advisors is headquartered in New York, NY.

What is Perceptive Advisors's total asset value?

Perceptive Advisors has around in total assets under management.

How many investments has Perceptive Advisors made?

Perceptive Advisors has made 306 investments.

What has Perceptive Advisors invested in?

Perceptive Advisors has made numerous investments in companies like Synthego , Crescent Biopharma, and Merida Biosciences within the Biotechnology and Drug Discovery industries.

What has Perceptive Advisors invested in recently?

Perceptive Advisors's latest investment was on 26-Jun-2025 in Synthego , a company within the Biotechnology industry.

Perceptive Advisors investment portfolio

Perceptive Advisors Overview

Investor Type

Venture Capital

Status

Active

Professionals

30

Investments

306

Portfolio

65

Exits

184

Perceptive Advisors General Information

Company Description

Founded in 1999, Perceptive Advisors is a venture capital firm based in New York, New York. The firm pursues fundamental equity, long/short equity, and credit sector-oriented strategies, seeking to invest in publicly and privately held companies operating in the life sciences, pharmaceutical, biotechnology, and health tech sectors. The firm makes venture capital investments.

Business Details

Website

www.perceptivelife.com

Year Founded

1999

Investor Status

Actively Seeking New Investments

Trade Association

Principles for Responsible Investment (PRI)

Primary Investor Type

Venture Capital

Other Investor Types

Hedge Fund

PE/Buyout

Corporate Office

51 Astor Place
10th floor
New York, NY 10003
United States

+1 (646)



Perceptive Advisors Investments (306)

Company Name	Deal Date	Deal Type	Industry	Company Stage
Synthego	26-Jun-2025	Buyout/LBO	Biotechnology	Bankruptcy: Admin/Reorg
Crescent Biopharma	16-Jun-2025		Drug Discovery	Generating Revenue
Merida Biosciences	08-Apr-2025		Biotechnology	Pre-Clinical Trials
Caris Life Sciences	01-Apr-2025		Biotechnology	Generating Revenue/Not Profitable
Zucara	28-Feb-2025		Drug Discovery	Clinical Trials - Phase 2
Solid Biosciences	18-Feb-2025		Biotechnology	Generating Revenue
Kardigan	10-Jan-2025		Drug Discovery	Clinical Trials - Phase 1
Outset Medical	08-Jan-2025		Other Devices and Supplies	Generating Revenue/Not Profitable
Traws Pharma	30-Dec-2024	PIPE	Drug Discovery	Generating Revenue
RAPT Therapeutics	27-Dec-2024	PIPE	Drug Discovery	Generating Revenue

You’re viewing 10 of 306 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Perceptive Advisors Exits (184)

Company Name	Exit Date	Exit Type
Cogent Biosciences	09-Jul-2025	Public Investment 2nd Offering
Caris Life Sciences	18-Jun-2025
Omada	06-Jun-2025
Synthego	06-May-2025
Cerebral Therapeutics	04-Apr-2025
Sionna Therapeutics	06-Feb-2025
Beta Bionics	30-Jan-2025
Verrica Pharmaceuticals	21-Nov-2024
Spyre Therapeutics	19-Nov-2024	Public Investment 2nd Offering
OnKure Therapeutics	04-Oct-2024	Reverse Merger

You’re viewing 10 of 184 exits. Get the full list »

Perceptive Advisors Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.